Verisante Technology Price to Free Cash Flow Ratio 2012-2024 | VRSEF
Historical price to free cash flow ratio values for Verisante Technology (VRSEF) since 2012.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Verisante Technology Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-05 | 0.00 | 0.00 | |
| 2024-12-31 | 0.01 | $0.00 | 0.00 |
| 2024-06-30 | 0.00 | $0.00 | 0.00 |
| 2024-03-31 | 0.01 | $0.00 | 0.00 |
| 2023-09-30 | 0.01 | $-0.01 | 0.00 |
| 2023-06-30 | 0.01 | $0.00 | 0.00 |
| 2023-03-31 | 0.00 | $0.02 | 0.01 |
| 2022-12-31 | 0.01 | $0.02 | 0.63 |
| 2022-09-30 | 0.01 | $0.02 | 0.62 |
| 2022-06-30 | 0.01 | $-0.01 | 0.00 |
| 2017-09-30 | 0.01 | $-0.04 | 0.00 |
| 2017-06-30 | 0.02 | $-0.03 | 0.00 |
| 2017-03-31 | 0.01 | $-0.03 | 0.00 |
| 2016-12-31 | 0.02 | $-0.03 | 0.00 |
| 2016-09-30 | 0.03 | $-0.04 | 0.00 |
| 2016-06-30 | 0.02 | $-0.06 | 0.00 |
| 2016-03-31 | 0.03 | $-0.05 | 0.00 |
| 2015-12-31 | 0.04 | $-0.06 | 0.00 |
| 2015-09-30 | 0.06 | $-0.08 | 0.00 |
| 2015-06-30 | 0.09 | $-0.09 | 0.00 |
| 2015-03-31 | 0.09 | $-0.11 | 0.00 |
| 2014-12-31 | 0.08 | $-0.15 | 0.00 |
| 2014-09-30 | 0.13 | $-0.11 | 0.00 |
| 2014-06-30 | 0.14 | $-0.17 | 0.00 |
| 2014-03-31 | 0.17 | $-0.28 | 0.00 |
| 2013-12-31 | 0.22 | $-0.37 | 0.00 |
| 2013-09-30 | 0.22 | $-0.51 | 0.00 |
| 2013-06-30 | 0.32 | $-0.56 | 0.00 |
| 2013-03-31 | 0.51 | $-0.45 | 0.00 |
| 2012-12-31 | 0.52 | $-0.47 | 0.00 |
| 2012-09-30 | 0.59 | $-0.65 | 0.00 |
| 2012-06-30 | 0.46 | $-0.52 | 0.00 |
| 2012-03-31 | 0.64 | $-0.50 | 0.00 |
| 2011-12-31 | 0.64 | $-0.31 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Verisante Technology, Inc. operates as a medical device company engaged in the development of innovative systems for the early detection of cancer. It develops and offers a range of compact, non?invasive cancer detection devices for many of the most common cancers, including gastro?intestinal, colorectal and cervical cancers. The Company's Verisante Aura series is a novel multimodality imaging and spectroscopy system designed to aid in the early detection of skin cancer. Other product offered by the company includes Verisante Core series and Authenticare- a pre-production prototype of a pharmaceutical tablet analyzer for the authentication of solid dosage pharmaceuticals. Verisante Technology, Inc. is based in Vancouver, British Columbia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.668B | 87.45 |
| Thermo Fisher Scientific (TMO) | United States | $151.715B | 18.35 |
| Edwards Lifesciences (EW) | United States | $45.473B | 29.82 |
| Alcon (ALC) | Switzerland | $43.302B | 29.26 |
| IDEXX Laboratories (IDXX) | United States | $42.214B | 48.51 |
| DexCom (DXCM) | United States | $33.984B | 52.53 |
| IQVIA Holdings (IQV) | United States | $26.351B | 14.76 |
| Mettler-Toledo (MTD) | United States | $24.614B | 29.27 |
| STERIS (STE) | Ireland | $23.975B | 26.41 |
| Waters (WAT) | United States | $20.898B | 29.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.583B | 0.00 |
| Hologic (HOLX) | United States | $14.336B | 15.58 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $10.026B | 78.69 |
| Masimo (MASI) | United States | $9.324B | 34.39 |
| Globus Medical (GMED) | United States | $8.112B | 19.33 |
| Teleflex (TFX) | United States | $5.426B | 8.96 |
| Glaukos (GKOS) | United States | $5.314B | 0.00 |
| TransMedics (TMDX) | United States | $4.703B | 102.24 |
| Integer Holdings (ITGR) | United States | $4.233B | 22.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.481B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.505B | 14.92 |
| Veracyte (VCYT) | United States | $2.151B | 30.18 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 23.53 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Alphatec Holdings (ATEC) | United States | $1.861B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.384B | 0.00 |
| Artivion (AORT) | United States | $1.236B | 115.80 |
| Pulse Biosciences (PLSE) | United States | $1.150B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.054B | 5.60 |
| Beta Bionics (BBNX) | United States | $0.827B | 0.00 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.03 |
| RxSight (RXST) | United States | $0.611B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.567B | 13.30 |
| OrthoPediatrics (KIDS) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.497B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.390B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.368B | 9.79 |
| Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.342B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Sight Sciences (SGHT) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 49.20 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.29 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |